Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 3, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC | NASDAQ | Diagnostics & Research | A | $51.07B | $639.60 | -4.60% | $1.45B | 50.28x | 1.17 | United States | 50 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $44.80B | $339.11 | 0.31% | $151.92M | 1,093.90x | 19.74 | United States | 43 |
| LVS | LAS VEGAS SANDS CORP | NYSE | Resorts & Casinos | A | $37.62B | $55.64 | 5.52% | $4.05B | 25.18x | 12.50 | United States | 38 |
| THC | TENET HEALTHCARE CORP | NYSE | Medical Care Facilities | A | $16.53B | $188.03 | -0.66% | $3.48B | 12.69x | 5.16 | United States | 31 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $13.72B | $137.63 | 1.15% | $679.20M | 31.93x | 0.42 | United States | 62 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.17B | $167.29 | 1.70% | $182.64M | -27.93x | 1.87 | Ireland | 16 |
| PEGA | PEGASYSTEMS INC | NASDAQ | Software - Application | A | $7.39B | $43.57 | -0.27% | $373.32M | 26.90x | 1.17 | United States | 50 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $4.10B | $17.89 | 1.25% | -$33.04M | 54.21x | 2.40 | United States | 50 |
| CALX | CALIX INC | NYSE | Software - Application | A | $3.14B | $47.32 | 5.93% | $10.21M | -473.20x | 0.19 | United States | 33 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $3.02B | $38.16 | 0.21% | $57.00M | 97.85x | 0.09 | United States | 45 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.04B | $157.34 | -0.84% | $301.16M | 9.12x | 1.82 | United States | 50 |
| ADUS | ADDUS HOMECARE CORP | NASDAQ | Medical Care Facilities | A | $1.95B | $105.32 | 1.78% | $144.97M | 22.17x | 0.36 | United States | 60 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.62B | $51.06 | 1.49% | $194.43M | 12.73x | 1.45 | United States | 46 |
| FIVN | FIVE9 INC | NASDAQ | Software - Infrastructure | A | $1.41B | $17.98 | 1.81% | $127.81M | 42.81x | 1.28 | United States | 58 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.17B | $4.07 | 1.75% | $137.29M | 50.88x | 0.68 | United States | 41 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $898.01M | $12.35 | 2.40% | $98.00M | 12.73x | 0.23 | United States | 47 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $874.00M | $31.16 | 2.33% | $174.52M | 7.11x | 5.24 | United States | 39 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $699.31M | $18.74 | 4.34% | $145.14M | N/A | 6.80 | Mexico | 24 |
| EMBC | EMBECTA CORP | NASDAQ | Medical Instruments & Supplies | A | $640.13M | $10.94 | 3.11% | $294.70M | 6.67x | -2.68 | United States | 43 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $550.22M | $18.01 | 1.41% | $86.84M | 48.68x | 2.69 | United States | 31 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $536.84M | $4.23 | 5.75% | $18.04M | -35.25x | 0.49 | United States | 20 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $238.46M | $1.72 | 3.61% | $51.06M | -43.00x | 4.04 | United States | 12 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $203.56M | $10.92 | 1.49% | $11.65M | N/A | 0.39 | United States | 27 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $167.57M | $8.24 | -0.24% | $24.16M | 31.69x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.